MBBS, PGT (Internal Medicine), MPhil (Radiotherapy)
Cancer Specialist
Senior Consultant, Oncology
United Hospital Ltd, Dhaka
Dr. Ashim Kumar Sengupta’s Chamber & Appointment
United Hospital Ltd, Dhaka
Address: Plot # 15, Road # 71, Gulshan, Dhaka
Visiting Hour: 9am to 6pm (Closed: Friday)
Appointment: 10666
Dr. Ashim Kumar Sengupta: Expert in Clinical & Radiation Oncology
Dr. Ashim Kumar Sengupta is a highly experienced Oncologist practicing in Dhaka, known for his comprehensive and patient-centered approach to cancer care. As a veteran in the field, he combines specialized knowledge in internal medicine with advanced radiotherapy to provide holistic treatment plans for complex malignancies.
Academic and Professional Qualifications
Dr. Sengupta’s credentials reflect a broad and deep understanding of both general medical management and specialized cancer therapy:
- MBBS: Primary medical degree in Medicine and Surgery.
- PGT (Internal Medicine): Post-Graduate Training in Internal Medicine, which allows him to manage the various systemic health issues that often accompany cancer.
- MPhil (Radiotherapy): Master of Philosophy in Radiotherapy, signifying high-level academic and clinical expertise in using radiation to treat tumors.
Currently, he holds the position of Senior Consultant in the Department of Oncology at United Hospital Ltd, one of the most prestigious healthcare facilities in Bangladesh.
Areas of Clinical Expertise
At United Hospital, Dr. Sengupta utilizes some of the country’s most advanced medical technology to treat cancer. His primary areas of focus include:
- Radiation Oncology: Designing and supervising precise radiation treatments to target cancer cells effectively.
- Multidisciplinary Cancer Care: Collaborating with surgeons and pathologists to create personalized, integrated treatment pathways.
- Internal Medical Management: Monitoring and treating the side effects of chemotherapy and radiation to ensure patient safety and comfort.
- Palliative Care: Providing supportive care to improve the quality of life for patients with advanced-stage illnesses.
